MedTrace Logo

Thromboelastography in Non-elective Cesarean Delivery

NCT01514591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2013-06-21

No results posted yet for this study

Summary

The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Alex Butwick, MBBS, FRCA · Stanford University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01514591 on ClinicalTrials.gov